Research2025 · AAPM Blue Ribbon Poster

Teaching a model the clinic’s language.

AAPM poster describing a locally hosted language-model pipeline for TG-263 naming quality assurance
Original AAPM 2025 research poster · Open the full poster below for readable figures · Source

A treatment-target name is a small piece of text with a large job: it has to preserve clinical intent while fitting a shared naming convention. This project explores where local language models can help, and where a clinician still needs to look closely.

Locally hosted language models for radiation-oncology naming quality assurance
Original public recordings

Watch the study.

Preview images load from this site. YouTube connects only after you press play.

Why naming matters

Radiation-oncology teams work with treatment targets and organs that need consistent, interpretable labels. The American Association of Physicists in Medicine (AAPM) Task Group 263 provides a standard nomenclature, but real clinical names can still vary widely.

The research question was whether locally hosted large language models could help bring clinical target names into that convention without relying on an external model service.

The approach

The pipeline combined structured prompting, a naming ruleset, and language-model processing. It compared a Qwen3:8B workflow with a Phi4:14B / Qwen3:8B mixture-of-prompting-experts approach. It evaluated 1,000 clinical names and used explicit rule checks to assess whether each output followed the TG-263 naming requirements.

Locally hosted models make deployment location an explicit part of the design. This is distinct from demonstrating the privacy, reliability, or readiness of a complete clinical product.

The result, and the important caveat

All evaluated outputs passed the implemented TG-263 ruleset after correction. Reported mean response time decreased from 89 to 22 seconds. The poster also documents examples in which a corrected name changed the author’s intended meaning.

Syntactic compliance and semantic correctness are different outcomes. A technically valid name is not necessarily the right clinical name. The result supports a reviewed quality-assurance workflow, with clinical interpretation kept in the loop.

Sharing the work

The study received a Blue Ribbon Poster designation at the AAPM 2025 Annual Meeting. The full poster provides the methods, examples, and limitations behind the summary.

Sources & further reading

Research summary updated October 5, 2026. Findings describe the linked study and do not establish clinical readiness beyond its evaluation.